This finding may assist in elucidating the dual role of eIF2α phosphorylation associated with PERK in promoting cell survival and metastasis, as well as inducing immunogenic cell death in tumor cells following treatment with specific anticancer agents. This evidence concerns the gene EIF2AK3 and neoplasm.